Open access
Sep 2026
Anti-tumor activity of valproic acid in EBV-positive Burkitt lymphoma via PFN2-associated PI3K/AKT pathway repression
VPA exerts potent anti-tumor activity against EBV-positive BL in vitro and in multiple xenograft models, associated with PFN2 downregulation and suppressed PI3K/AKT signaling.
Yong-Liang Zheng, Yu-Xiu Yang, Shou-Hua Zhang et al.
· Frontiers in Pharmacology · 0 citations